Journal profile · Allergy
Contact Dermatitis
ISSN 0105-1873 · eISSN 1600-0536 · Wiley-Blackwell Publishing Ltd · DENMARK · Monthly · Founded 1975
Contact Dermatitis: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 4; hybrid open access; APC about USD 5,060; median 89 days to acceptance (105 articles, last 24 months); community-reported acceptance: fairly easy; 199 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Contact Dermatitis is published by Wiley-Blackwell Publishing Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Contact Dermatitis and Allergies, Occupational exposure and asthma and Allergic Rhinitis and Sensitization, together about 59.8% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Contact Dermatitis is designed primarily as a journal for clinicians who are interested in various aspects of environmental dermatitis. This includes both allergic and irritant (toxic) types of contact dermatitis, occupational (industrial) dermatitis and consumers' dermatitis from such products as cosmetics and toiletries. Delayed hypersensitivity reactions to systemic drugs and implanted medical devices where cutaneous testing has been utilised are also of interest. The journal aims at promoting and maintaining communication among dermatologists, occupational physicians, allergists and clinical immunologists, as well as chemists and research workers. Papers are invited on clinical observations, diagnosis and methods of investigation of patients, therapeutic measures, organisation and legislation relating to the control of occupational and consumers' contact dermatitis, preventive measures and educational advice. A major section is devoted to Short Communications for the presentation of information on new contact allergens or other substances. Papers concerned with the chemistry and immunology of allergic contact dermatitis are invited for the purpose of bringing to the notice of the clinician, knowledge of important recent advances in the understanding of its theoretical basis, as well as papers on the physiology and pathology of the horny layer and epidermis in relation to its disturbance in the genesis of irritant dermatitis. An important objective of the Editor and Publisher is the rapid processing of submitted manuscripts, so that an early decision can be made on their acceptance, and final publication can be expedited by a short printing time.
From the journal's Aims & Scope
Research area (LetPub): Allergy
Editor-in-chief Mark WilkinsonPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 5, United States 2, Germany 2, Denmark 2, France 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Contact Dermatitis and AllergiesMedicine40.9%
- Occupational exposure and asthmaMedicine12.1%
- Allergic Rhinitis and SensitizationMedicine6.9%
- Drug-Induced Adverse ReactionsMedicine6.5%
- Dermatology and Skin DiseasesMedicine5.6%
- Pesticide Exposure and ToxicityAgricultural and Biological Sciences4.4%
- Nail Diseases and TreatmentsMedicine3%
- Skin Protection and AgingMedicine2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Dermatology | Zone 1 |
| Minor | Allergy | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Allergy | Zone 3 |
| Minor | Dermatology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Dermatology | Zone 1 |
| Minor | Allergy | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4LetPub ·
- Impact factor (publisher)
- 4.1Publisher website ·
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- CiteScore (publisher)
- 4.4Publisher website ·
- CiteScore (publisher) 2025
- 4.4Publisher website ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 1.34LetPub ·
- h-index
- 88LetPub ·
- h-index
- 140OpenAlex ·
- i10-index
- 7,424OpenAlex ·
- 2-year mean citedness
- 2OpenAlex ·
- Self-citation rate
- 29.3%LetPub ·
- Share of gold OA articles
- 62.09%LetPub ·
Volume
- Articles per year
- 112LetPub ·
- Articles per year (publisher) 2025
- 172Publisher website ·
- Downloads per year (publisher) 2025
- 518,835Publisher website ·
Articles by year OpenAlex count · 13,144 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 183 | 121 | 59 |
| 2025 | 199 | 134 | 373 |
| 2024 | 278 | 175 | 889 |
| 2023 | 230 | 164 | 1,314 |
| 2022 | 247 | 110 | 2,357 |
| 2021 | 274 | 82 | 2,522 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
89 daysMedian, submission to acceptance · P25–P75 60 days – 118 days
- Acceptance to online
- median 15 days (106 articles)
- Submission to online
- median 102 days
- Sample
- 105 articles with submission and acceptance dates (408 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 37%Publisher website ·
- Acceptance rate (publisher) 2025
- 37%Publisher website ·
- Submission to first decision
- 24 daysPublisher website ·
- Submission to first decision 2025
- 24 daysPublisher website ·
- Submission to acceptance 2025
- 98 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,060 / EUR 4,230 / GBP 3,380 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Required
- Cover letter
- Optional
Article types accepted4
- contact pointiii. Contact PointLength not stated
- letter to the editoriv. Letter to the EditorLength not stated
- original articlei. Original ArticleLength not stated
- reviewii. ReviewLength not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Expects Data Sharing
Please review Wiley’s policy here. This journal expects and peer review data sharing.
Source ↗Publisher website ·- Publication ethics Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Single-blind peer review Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Preprints
Accepts preprint articles Model summary
This journal accepts articles previously published on preprint servers.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- DENMARK
- Language
- English
- Frequency
- Monthly
- Founded
- 1975
- ISSN
- 0105-1873
- Electronic ISSN
- 1600-0536
- Society / sponsor
- European Society of Contact Dermatitis
- Latest issue on the website
- Volume 95, Issue 4 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Contact Dermatitis
What CAS zone is Contact Dermatitis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Contact Dermatitis is in Zone 1 of Medicine, and in Zone 1 of the minor category Dermatology / Allergy; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Contact Dermatitis?
The latest impact factor listed by LetPub is 4; CiteScore 4.4, h-index 140.
How long does peer review take at Contact Dermatitis?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 60–118 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 37% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Contact Dermatitis?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Graphical abstract: Required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Contact Dermatitis based?
Of the 16 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (5), United States (2) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Contact Dermatitis?
According to LetPub and DOAJ records, Contact Dermatitis is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Contact Dermatitis open access, and what is the APC?
Contact Dermatitis is a hybrid journal. For open-access publication: APC about USD 5,060.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .